Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
De lange en onzekere weg naar SARS-CoV-2-vaccins
aug 2020 | Vaccinatie, Virale infecties